Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             165 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A candidate metastasis-associated DNA marker for ductal mammary carcinoma Achary, Patnala Mohan R
2003
2 p. R52-R58
artikel
2 Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study Oh, Sang Woo
2011
2 artikel
3 A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study Kim, Hyung-cheol
2012
2 artikel
4 Akt kinases in breast cancer and the results of adjuvant therapy Stål, Olle
2003
2 p. R37-R44
artikel
5 Alternative TFAP2A isoforms have distinct activities in breast cancer Berlato, Chiara
2011
2 artikel
6 Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer Cheng, Qing
2012
2 artikel
7 Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers Yang, Xiaohong R
2012
2 artikel
8 An investigation of soy intake and mammographic characteristics in Hawaii Maskarinec, Gertraud
2001
2 p. 134-141
artikel
9 Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action Kampa, Marilena
2004
2 p. R63-R74
artikel
10 A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer Brandão, Rita D
2013
2 artikel
11 A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer Robertson, John FR
2013
2 artikel
12 Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression Liu, Mohan
2012
2 artikel
13 Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling Roy, Lopamudra Das
2013
2 artikel
14 Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment Montero Girard, Guadalupe
2007
2 artikel
15 Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer Jacquemier, Jocelyne
2009
2 artikel
16 Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis Blixt, Ola
2011
2 artikel
17 Breast asymmetry and predisposition to breast cancer Scutt, Diane
2006
2 artikel
18 Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase McSherry, Elaine A
2011
2 artikel
19 Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study Ward, Heather
2008
2 artikel
20 Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers Kotsopoulos, Joanne
2012
2 artikel
21 Breast implants following mastectomy in women with early-stage breast cancer: prevalence and impact on survival Le, Gem M
2005
2 p. R184-R193
artikel
22 Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials Kyndi, Marianne
2008
2 artikel
23 CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer Liu, Shuzhen
2012
2 artikel
24 Characterizing mammographic images by using generic texture features Häberle, Lothar
2012
2 artikel
25 CIP2A is a target of bortezomib in human triple negative breast cancer cells Tseng, Ling-Ming
2012
2 artikel
26 Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay Perreard, Laurent
2006
2 artikel
27 Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study Tőkés, Anna-Mária
2005
2 p. R296-R305
artikel
28 Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors Blackman, Brigitte
2005
2 p. R248-R255
artikel
29 Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast von Minckwitz, Gunter
2008
2 artikel
30 C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer Schlotter, Claus M
2003
2 p. R30-R36
artikel
31 Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study Benusiglio, Patrick R
2005
2 p. R204-R209
artikel
32 Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk Baynes, Caroline
2007
2 artikel
33 Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients Lee, Daphne SC
2012
2 artikel
34 Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancer Strati, Areti
2013
2 artikel
35 Confirmation of double-peaked time distribution of mortality among Asian breast cancer patients in a population-based study Gao, Fei
2007
2 artikel
36 CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors Ambrosone, Christine B
2003
2 p. R45-R51
artikel
37 DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer Yin, Xuedong
2013
2 artikel
38 Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer Dusek, Rachel L
2012
2 artikel
39 Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity Hawes, Debra
2006
2 artikel
40 Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG) Wall, Alexander
2008
2 artikel
41 Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships Park, Kwang-Hwa
2005
2 p. R238-R247
artikel
42 Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan Gibby, Krissa
2012
2 artikel
43 Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo Wärnberg, Fredrik
2006
2 artikel
44 Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial Albada, Akke
2012
2 artikel
45 Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers Maia, Ana-Teresa
2012
2 artikel
46 Effects of childhood body size on breast cancer tumour characteristics Li, Jingmei
2010
2 artikel
47 Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study Lundgren, Katja
2012
2 artikel
48 Effects of lovastatin on breast cancer cells: a proteo-metabonomic study Klawitter, Jelena
2010
2 artikel
49 Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers Zvelebil, Marketa
2013
2 artikel
50 Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer Déry, Marc-André
2013
2 artikel
51 Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers Yan, Max
2012
2 artikel
52 ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer Pinhel, Isabel
2012
2 artikel
53 Estrogen receptor beta inhibits transcriptional activity of hypoxia inducible factor-1 through the downregulation of arylhydrocarbon receptor nuclear translocator Lim, Wonchung
2011
2 artikel
54 Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen Wu, Xianglin
2011
2 artikel
55 Estrogen receptor β represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity Lindberg, Karolina
2011
2 artikel
56 Evaluation of biological pathways involved in chemotherapy response in breast cancer Tordai, Attila
2008
2 artikel
57 Evaluation of the current knowledge limitations in breast cancer research: a gap analysis Thompson, Alastair
2008
2 artikel
58 Exploring the link between MORF4L1 and risk of breast cancer Martrat, Griselda
2011
2 artikel
59 Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer Hannafon, Bethany N
2011
2 artikel
60 Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer Katchman, Benjamin A
2013
2 artikel
61 Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer Nadler, Yasmine
2008
2 artikel
62 FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis Elbauomy Elsheikh, Somaia
2007
2 artikel
63 Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1 Hutcheson, Iain R
2011
2 artikel
64 Functional characterization of the 19q12 amplicon in grade III breast cancers Natrajan, Rachael
2012
2 artikel
65 Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients Román-Pérez, Erick
2012
2 artikel
66 Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy Niméus-Malmström, Emma
2008
2 artikel
67 Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression Clarkson, Richard WE
2004
2 p. R92-R109
artikel
68 Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland Nyante, Sarah J
2011
2 artikel
69 Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer Li, Jingmei
2010
2 artikel
70 Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer Crawford, Nigel PS
2006
2 artikel
71 Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A Murray, Tessa J
2006
2 artikel
72 Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer Cox, David G
2005
2 p. R171-R175
artikel
73 HER4 in breast cancer: comparison of antibodies against intra- and extra-cellular domains of HER4 Tovey, Sian M
2006
2 artikel
74 HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma Samarajeewa, Nirukshi U
2013
2 artikel
75 High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome Schmitz, Klaus Jürgen
2005
2 p. R194-R203
artikel
76 HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease Habel, Laurel A
2013
2 artikel
77 Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy Fillmore, Christine M
2008
2 artikel
78 Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity Vincent-Salomon, Anne
2007
2 artikel
79 Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study Broeks, Annegien
2007
2 artikel
80 Id-1 is not expressed in the luminal epithelial cells of mammary glands Uehara, Norihisa
2003
2 p. R25-R29
artikel
81 Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53 mutation and poor clinical outcom King, Sharon I
2012
2 artikel
82 Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation Toulany, Mahmoud
2011
2 artikel
83 Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line Annab, Lois A
2000
2 p. 139-148
artikel
84 Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells Abalsamo, Laura
2012
2 artikel
85 Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer Lin, Chin-Yo
2007
2 artikel
86 Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim Periyasamy-Thandavan, Sudharsan
2012
2 artikel
87 Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II Rice, Megan S
2012
2 artikel
88 Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis Reed, Johanna R
2009
2 artikel
89 Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer Yoshimura, Noriko
2004
2 p. R46-R55
artikel
90 In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores Sano, Kohei
2012
2 artikel
91 Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3 Stein, Torsten
2004
2 p. R75-R91
artikel
92 Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene Hockings, Jennifer K
2008
2 artikel
93 Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial? Munro, Alison F
2013
2 artikel
94 Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis Keam, Bhumsuk
2011
2 artikel
95 Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo Wang, Yi-hua
2005
2 p. R220-R228
artikel
96 Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer Mitra, Aparna
2008
2 artikel
97 Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing Schmidt, Marcus
2005
2 p. R256-R266
artikel
98 Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice Burga, Laura N
2011
2 artikel
99 Loss of TGF-β or Wnt5a results in an increase in Wnt/β-catenin activity and redirects mammary tumour phenotype Roarty, Kevin
2009
2 artikel
100 Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer Knappskog, Stian
2012
2 artikel
101 Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model Bumaschny, Viviana
2004
2 p. R116-R129
artikel
102 Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial Markopoulos, Christos
2010
2 artikel
103 Mechanisms of suberoylanilide hydroxamic acid inhibition of mammary cell growth Said, Thenaa K
2001
2 p. 122-133
artikel
104 Microwave imaging for neoadjuvant chemotherapy monitoring: initial clinical experience Meaney, Paul M
2013
2 artikel
105 miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention Srivastava, Niloo
2011
2 artikel
106 miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs Riaz, Muhammad
2013
2 artikel
107 Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy Teng, Yvonne Hui-Fang
2011
2 artikel
108 Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study Gierach, Gretchen L
2008
2 artikel
109 NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models Jensen, Michael Rugaard
2008
2 artikel
110 Occurrence of breast cancer subtypes in adolescent and young adult women Keegan, Theresa HM
2012
2 artikel
111 Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling Harrison, Hannah
2013
2 artikel
112 Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium Meier-Abt, Fabienne
2013
2 artikel
113 Peroxisome proliferator-activated receptor-γ protects ERBB2-positive breast cancer cells from palmitate toxicity Kourtidis, Antonis
2009
2 artikel
114 Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis Borges, Sahra
2013
2 artikel
115 PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer Liedtke, Cornelia
2008
2 artikel
116 Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort Jacobs, Eric J
2006
2 artikel
117 Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry Salido, Marta
2005
2 p. R267-R273
artikel
118 Potential prognostic value of heat-shock protein 90 in the presence of phosphatidylinositol-3-kinase overexpression or loss of PTEN, in invasive breast cancers Song, Chang Hoon
2010
2 artikel
119 Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer Sanchez, Cesar G
2011
2 artikel
120 Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins Asakawa, Hideki
2010
2 artikel
121 Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells Britt, Kara L
2009
2 artikel
122 Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II Fortner, Renée T
2013
2 artikel
123 Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study Cronin-Fenton, Deirdre P
2010
2 artikel
124 Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression Zu, Xuyu
2011
2 artikel
125 Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential Kittrell, Frances S
2011
2 artikel
126 Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer Su, Fuqin
2012
2 artikel
127 Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration Zhou, Changhua
2012
2 artikel
128 Quantitative assays for the measurement of HER1-HER2 heterodimerization and phosphorylation in cell lines and breast tumors: applications for diagnostics and targeted drug mechanism of action DeFazio-Eli, Lisa
2011
2 artikel
129 RAC1 GTPase plays an important role in γ-irradiation induced G2/M checkpoint activation Yan, Ying
2012
2 artikel
130 Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers Yan, Max
2011
2 artikel
131 Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026] Powles, Trevor
2006
2 artikel
132 Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer Papantoniou, Vassilios J
2004
2 p. R56-R62
artikel
133 Relationship of serum estrogens and estrogen metabolites to postmenopausal breast cancer risk: a nested case-control study Falk, Roni T
2013
2 artikel
134 Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer Benoy, Ina H
2005
2 p. R210-R219
artikel
135 Relevance of PTEN loss in brain metastasis formation in breast cancer patients Wikman, Harriet
2012
2 artikel
136 Reproductive aging-associated common genetic variants and the risk of breast cancer He, Chunyan
2012
2 artikel
137 Risk of breast cancer in Lynch syndrome: a systematic review Win, Aung Ko
2013
2 artikel
138 Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy Zhang, Wei
2011
2 artikel
139 Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo Khurana, Ashwani
2012
2 artikel
140 Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers Friedman, Eitan
2006
2 artikel
141 SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case–control study Lilla, Carmen
2005
2 p. R229-R237
artikel
142 Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer Naderi, Ali
2011
2 artikel
143 Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice Wang, Bei
2012
2 artikel
144 Targets of miR-200c mediate suppression of cell motility and anoikis resistance Howe, Erin N
2011
2 artikel
145 T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers Rody, Achim
2009
2 artikel
146 The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers Spurdle, Amanda B
2005
2 p. R176-R183
artikel
147 The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort Lee, Eunjung
2011
2 artikel
148 The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome Butt, Alison J
2008
2 artikel
149 The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines De Santi, Mauro
2011
2 artikel
150 The multiplex bead array approach to identifying serum biomarkers associated with breast cancer Kim, Byoung Kwon
2009
2 artikel
151 TLE3 as a candidate biomarker of response to taxane therapy Kulkarni, Swati A
2009
2 artikel
152 TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells Howlin, Jillian
2008
2 artikel
153 Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways Lim, Elgene
2010
2 artikel
154 Transforming growth factor-β induces Cdk2 relocalization to the cytoplasm coincident with dephosphorylation of retinoblastoma tumor suppressor protein Brown, Kimberly A
2004
2 p. R130-R139
artikel
155 Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo Barok, Mark
2011
2 artikel
156 Trichostatin A enhances acetylation as well as protein stability of ERα through induction of p300 protein Kim, Sung-Hye
2010
2 artikel
157 Triple-negative breast cancers are increased in black women regardless of age or body mass index Stead, Lesley A
2009
2 artikel
158 Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone Sloan, Erica K
2006
2 artikel
159 Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms Hancox, Rachael A
2009
2 artikel
160 Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells Yanochko, Gina M
2006
2 artikel
161 Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer Gholami, Sepideh
2013
2 artikel
162 Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study Yao, Song
2012
2 artikel
163 Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk Abbas, Sascha
2008
2 artikel
164 Waist–hip ratio and breast cancer risk in urbanized Nigerian women Adebamowo, Clement A
2003
2 p. R18-R24
artikel
165 WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer Kleer, Celina G
2004
2 p. R110-R115
artikel
                             165 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland